Smith & Nephew plc (SNN)
NYSE: SNN · Real-Time Price · USD
34.08
-0.23 (-0.67%)
At close: Mar 9, 2026, 4:00 PM EDT
34.08
0.00 (0.00%)
After-hours: Mar 9, 2026, 7:00 PM EDT
Smith & Nephew Revenue
In the year 2025, Smith & Nephew had annual revenue of $6.16B with 6.09% growth. Smith & Nephew had revenue of $3.20B in the half year ending December 31, 2025, with 13.78% growth.
Revenue (ttm)
$6.16B
Revenue Growth
+6.09%
P/S Ratio
2.31
Revenue / Employee
$341,307
Employees
18,060
Market Cap
14.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.16B | 354.00M | 6.09% |
| Dec 31, 2024 | 5.81B | 261.00M | 4.70% |
| Dec 31, 2023 | 5.55B | 334.00M | 6.40% |
| Dec 31, 2022 | 5.22B | 3.00M | 0.06% |
| Dec 31, 2021 | 5.21B | 652.00M | 14.30% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Koninklijke Philips | 20.94B |
| GE HealthCare Technologies | 20.63B |
| Zimmer Biomet Holdings | 8.23B |
| STERIS | 5.83B |
| DexCom | 4.66B |
| Globus Medical | 2.94B |
| Insulet | 2.71B |
| Bio-Rad Laboratories | 2.58B |